scispace - formally typeset
G

Gaia Spadarella

Researcher at University of Milan

Publications -  27
Citations -  596

Gaia Spadarella is an academic researcher from University of Milan. The author has contributed to research in topics: Medicine & Rivaroxaban. The author has an hindex of 10, co-authored 20 publications receiving 388 citations. Previous affiliations of Gaia Spadarella include University of Naples Federico II.

Papers
More filters
Journal ArticleDOI

Old and new oral anticoagulants: Food, herbal medicines and drug interactions

TL;DR: A critical review of VKAs and DOACs with focus on their potential for interactions with drugs, foods, herbs and over-the-counter medications is presented.
Journal ArticleDOI

The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis

TL;DR: Results of the large meta-analysis suggest that HCV-infected subjects experience an increased risk of CCD, which should be considered to plan specific cardiovascular prevention strategies in this clinical setting.
Journal ArticleDOI

Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs).

TL;DR: To increase patient's awareness of the risks and benefits of direct oral anticoagulants and, in turn, increase medication adherence, at each follow-up visit physicians should screen for priorities and motivational problems and assess any health system or personal barriers to medication adherence.
Journal ArticleDOI

The risk of osteoporosis in patients with liver cirrhosis: a meta-analysis of literature studies.

TL;DR: A meta‐analysis of literature studies on the association between cirrhosis and osteoporosis and the results show that there is no clear relationship between these conditions and each other.
Journal ArticleDOI

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta‐Analysis of Randomized Controlled Trials

TL;DR: A systematic review and meta‐analysis on efficacy and safety of BA compared with standard treatment in patients with hypercholesterolemia found that BA is associated with a significant reduction in low‐density lipoprotein cholesterol, total cholesterol, non–high‐density cholesterol, apolipoprotein B, and hs‐CRP compared withstandard treatment.